https://www.selleckchem.com/products/azd8186.html
There is evidence of improved adherence and treatment outcomes when patients' treatment preferences are considered, and shared decision making is utilized. We aimed to better understand treatment preferences among Australians with treatment-resistant depression (TRD), focusing on the specific treatment attributes that people value (such as effectiveness, risk of side effects and cost) and their relative importance. The risk-benefit trade-offs that characterize treatment choices were also examined. An online survey of 75 patients with ex
Like
Comment
Share
